Ceftriaxone

Product NDC: 70594-097
11-digit product format: 705940097
Labeler code: 70594
Product ID: 70594-097_b414c892-8c86-4df5-8085-737897006085
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Ceftriaxone
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Xellia Pharmaceuticals USA LLC
Application: ANDA091049
Marketing category: ANDA
Marketing start: 2022-01-06
Marketing end: 0000-00-00
Substance: CEFTRIAXONE SODIUM
Active strength: 2 g/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	70594-097		I	Inactivated by FDA		2026-09-09
excluded package	package	70594-097	70594-097-02	I	Inactivated by FDA		2026-09-09

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 22 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70594-097-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70594-097-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70594-097-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70594-097-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70594-097-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70594-097-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70594-097-02	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70594-097-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70594-097-02	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70594-097-02	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70594-097-02	`367a005e9d99…`	`383a685ebd0f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A091049-001	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11
A091049-002	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11
A091049-003	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11
A091049-004	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091049-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091049-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091049-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091049-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	2018-06-11	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 104 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091049-001	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091049-002	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091049-003	AP	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A091049-004	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A091049-001	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A091049-002	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A091049-003	AP	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A091049-004	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A091049-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A091049-002	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A091049-003	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A091049-004	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A091049-001	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091049-002	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091049-003	AP	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091049-004	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A091049-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A091049-002	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A091049-003	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A091049-004	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A091049-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A091049-002	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A091049-003	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A091049-004	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A091049-001	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A091049-002	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A091049-003	AP	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A091049-004	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A091049-001	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A091049-002	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A091049-003	AP	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A091049-004	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A091049-001	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A091049-002	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A091049-003	AP	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A091049-004	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A091049-001	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A091049-002	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A091049-003	AP	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A091049-004	AP	1	`c0c555d07b60…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
67ae10d0-6c6a-4d52-a629-da83321859b9	Product name	3	20190201
01b0d089-049b-4c6d-8dfe-1bffad9be307	Product name	2	20180807
2d5083fe-71de-4fce-8d67-e9049cba775c	Product name	1	20150107
1037f4ca-3bea-c9c4-2af4-fa6387b0e81e	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70594-097-02	2024-07-30	C162847	48780-1	1030e365-1b01-111a-e063-dadaa90a10e2	CEFTRIAXONE FOR INJECTION, USP (For Intravenous or Intramuscular Use)
70594-097-02	2024-01-30	C162847	48780-1	1030e365-1b01-111a-e063-dadaa90a10e2	CEFTRIAXONE FOR INJECTION, USP (For Intravenous or Intramuscular Use)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70594-097-01	Ceftriaxone	1 in 1 VIAL	INJECTION, POWDER, FOR SOLUTION	1		1
70594-097-02	Ceftriaxone	25 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	25		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
70594-097-01	EA - Each	70594-097	e0c822a6-986b-4540-8976-0ab135d5ffa7	1	2022-08-04
70594-097-02	EA - Each	70594-097	517ac225-60e3-471e-993b-bace0ca476f8	1	2022-08-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70594-097	CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [XELLIA PHARMACEUTICALS USA LLC]	1	Legacy NDC, 2 package rows	20220430_2b662308-1d22-4f44-9d4f-088db5883212.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
023Z5BR09K	CEFTRIAXONE SODIUM	104376-79-6	CEFTRIAXONE SODIUM
75J73V1629	CEFTRIAXONE	73384-59-5	Ceftriaxone

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1665021	cefTRIAXone 1 GM Injection	PSN	2b662308-1d22-4f44-9d4f-088db5883212	1
1665046	cefTRIAXone 2 GM Injection	PSN	2b662308-1d22-4f44-9d4f-088db5883212	1
309092	cefTRIAXone 250 MG Injection	PSN	2b662308-1d22-4f44-9d4f-088db5883212	1
1665005	cefTRIAXone 500 MG Injection	PSN	2b662308-1d22-4f44-9d4f-088db5883212	1
1665021	ceftriaxone 1000 MG Injection	SCD	2b662308-1d22-4f44-9d4f-088db5883212	1
1665046	ceftriaxone 2000 MG Injection	SCD	2b662308-1d22-4f44-9d4f-088db5883212	1
309092	ceftriaxone 250 MG Injection	SCD	2b662308-1d22-4f44-9d4f-088db5883212	1
1665005	ceftriaxone 500 MG Injection	SCD	2b662308-1d22-4f44-9d4f-088db5883212	1
1665021	ceftriaxone 1 GM (as ceftriaxone sodium) Injection	SY	2b662308-1d22-4f44-9d4f-088db5883212	1
1665046	ceftriaxone 2 GM (as ceftriaxone sodium) Injection	SY	2b662308-1d22-4f44-9d4f-088db5883212	1
309092	ceftriaxone 250 MG (as ceftriaxone sodium) Injection	SY	2b662308-1d22-4f44-9d4f-088db5883212	1
1665005	ceftriaxone 500 MG (as ceftriaxone sodium) Injection	SY	2b662308-1d22-4f44-9d4f-088db5883212	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70594-097-01	70594009701	1 in 1 VIAL						Historical
70594-097-02	70594009702	25 VIAL in 1 CARTON (70594-097-02) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (70594-097-01)	25 vial	2022-01-06	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CEFTRIAXONE FOR INJECTION, USP (For Intravenous or Intramuscular Use)	Xellia Pharmaceuticals USA LLC	2022-04-07	HUMAN PRESCRIPTION DRUG LABEL	1